Parkinson's Disease
Progressive neurological disorder affecting movement due to dopamine-producing neuron loss.
TL;DR
Parkinson's disease is a progressive movement disorder caused by dopamine neuron loss. Levodopa is the cornerstone of treatment and no supplement slows progression — high-dose CoQ10 and creatine both failed in large trials. Nutrition interacts with medication timing, which is the detail that matters most.
Overview
Parkinson's disease is a progressive neurological condition caused by loss of dopamine-producing cells, leading to tremor, slowness, stiffness, and later balance and cognitive changes. Levodopa-based medication remains the most effective treatment, and regular exercise has the strongest evidence of any non-drug approach for maintaining function. No supplement has been shown to slow progression; high-dose CoQ10 (up to 2,400 mg/day) and creatine (10 g/day) both failed in large trials. Some nutrients still matter: vitamin D and calcium support bone health in a population prone to falls, and protein timing around levodopa doses affects how well the medication works. Any supplement should be discussed with the treating neurologist.
Common Symptoms
- •Resting tremor, often starting in one hand
- •Slowness of movement (bradykinesia)
- •Muscle stiffness and rigidity
- •Reduced facial expression and blinking
- •Shuffling gait and reduced arm swing
- •Loss of smell years before diagnosis
- •Constipation and REM sleep behaviour disorder
- •Soft speech and small handwriting
Common Causes
- •Age-related loss of substantia nigra dopamine neurons
- •Genetic variants — LRRK2, GBA, SNCA — in a minority
- •Pesticide and solvent exposure
- •Repeated head injury
- •Most cases have no single identifiable cause
Root Causes
Dopamine-producing neurons in the substantia nigra degenerate as alpha-synuclein misfolds into Lewy bodies. Motor symptoms appear only after roughly 60 to 80 per cent of these neurons are lost, which is why prodromal features — smell loss, constipation, dream-enactment — can precede diagnosis by a decade. Mitochondrial dysfunction and neuroinflammation are part of the cascade.
How It's Diagnosed
Diagnostic Markers
- Clinical diagnosis based on bradykinesia plus tremor or rigidity
- Clear response to levodopa supports the diagnosis
- DaTscan imaging where the picture is uncertain
- MRI mainly to exclude mimics
- Regular review of motor fluctuations and non-motor symptoms
When to See a Doctor
See a clinician for a new one-sided resting tremor, progressive slowness or stiffness, frequent falls, or acting out dreams with injury risk. New confusion or hallucinations in someone with Parkinson's needs prompt medication review.
Supplements Studied For This
Mucuna Pruriens
Mucuna pruriens seed powder is a natural source of L-DOPA, and several small clinical trials show it improves motor symptoms in Parkinson's disease comparably to standard levodopa, with faster onset and possibly fewer dyskinesias. It is not a substitute for prescribed therapy and requires neurologist supervision.
CoQ10
The definitive 600-patient randomised trial was stopped for futility; high-dose CoQ10 does not slow Parkinson's.
Diet & Lifestyle
Suggested Pattern
The practical dietary rule is protein timing: levodopa competes with dietary amino acids for absorption, so taking it 30-60 minutes before meals and shifting protein toward the evening often smooths motor fluctuations. A Mediterranean pattern supports cardiovascular and gut health, and fibre plus fluids matter because constipation is near-universal.
Eat more
- High-fibre foods — prunes, legumes, whole grains — for constipation
- Oily fish and olive oil within a Mediterranean pattern
- Adequate fluids through the day
- Protein concentrated at the evening meal if motor fluctuations are an issue
- Calcium and vitamin D for bone protection given fall risk
Avoid
- Protein-heavy meals at the same time as levodopa doses
- Alcohol, which worsens balance and interacts with sedating medication
- Grapefruit with certain Parkinson's medications — check with your pharmacist
- Large doses of vitamin B6 without advice — it affects levodopa without carbidopa
Supporting Research
Bacopa monnieri in Patients with Parkinson's Disease: A Pilot Study
Mucuna pruriens in Parkinson disease: a double-blind, randomized, controlled, crossover study
NADH in the treatment of Parkinson's disease: an open-label evaluation of oral and parenteral administration
Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study
Long-term safety and efficacy of Mucuna pruriens in Parkinson disease: a randomised controlled trial
Frequently Asked Questions
Who It Affects
Parkinson's disease affects roughly 1 per cent of people over 60, rising to around 4 per cent over 80, making it the fastest-growing neurological condition worldwide.
About one and a half times more common in men. Typical onset is around 60; young-onset Parkinson's before 50 accounts for roughly 1 in 10 cases.
Quick Facts
- •Caused by dopamine neuron loss with Lewy body formation
- •Smell loss and dream-enactment can precede diagnosis by years
- •CoQ10 and creatine trials both failed for futility
- •Levodopa must be timed away from protein
- •Exercise has the strongest progression data available
Lifestyle Tips
- •Exercise is the closest thing to a disease-modifying intervention — brisk walking, cycling, boxing and dance all have trial support
- •Take levodopa 30-60 minutes before food and keep timing consistent
- •Physiotherapy and speech therapy early, not as a last resort
- •Treat constipation aggressively — it affects levodopa absorption
- •Fall-proof the home before falls happen
- •Treat depression and anxiety actively; they affect up to half of patients
My Notes
Sign in to add personal notes
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.